Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML). Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML)

AML cell lines that underwent high throughput drug screening had baseline RNA sequencing done for the purpose of gene expression studies Overall design: Untreated cells growing in logrithmic phase underwent RNA extraction and sequencing